Asked by: Gregory Campbell (Democratic Unionist Party - East Londonderry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether Northern Ireland will receive funding through the Dame Barbara Windsor Dementia mission; and what her planned timetable for delivery of the mission is.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Spending and delivery plans for the Dame Barbara Windsor Dementia Mission are currently in development. The Dementia Mission Co-Chairs Hilary Evans and Professor Nadeem Sarwar have, and continue to, engage extensively across the sector to understand and develop the missions’ key aims, ensuring it addresses the challenges the sector faces and that patient voices are heard. This has informed the missions focus on three key pillars: biomarkers and experimental medicine; clinical trials infrastructure and innovation; and end-to-end implementation.
In March 2024, the Government hosted a roundtable and reception where charities, academics, investors, business leaders, and people with lived experience came together to further accelerate efforts to tackle this devastating illness, and to thank all those involved in supporting dementia research, including charities across the United Kingdom. This event made a series announcements, including: awarding a share of the £6 million of funding to 10 projects through Innovate UK’s Small Business Research Initiative (SBRI) dementia biomarker tools competition; the appointment of Scott Mitchell as the People’s Champion for the Dementia Mission; the appointment of Dr Ruth McKernan CBE as Chair of the Scientific Advisory Board for the Neurodegeneration Initiative, which will be a public-private partnership delivering the mission's objectives around biomarkers, boosting the number and speed of clinical trials in dementia and neurodegeneration, and working with regulatory bodies around the implementation of new treatments; and the appointment of the Medicines Discovery Catapult as the delivery partner for the establishment of the Neurodegeneration Initiative. The Dame Barbara Windsor Dementia Mission continues to develop its deliverables, and will announce further plans for their delivery in due course.
Asked by: Matt Western (Labour - Warwick and Leamington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the impact of air quality on the health of residents in Warwick and Leamington constituency.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The fraction of mortality attributable to particulate air pollution indicator, measured as PM2.5, represents the percentage of annual deaths from all causes in those aged 30 years old and older, attributed to PM2.5. In 2022, the latest year from which published data is available, the fraction of mortality attributable to particulate air pollution was 5.5% for Warwickshire, and 5.5% for Warwick.
The UK Health Security Agency (UKHSA) produces the estimates of the fraction of mortality attributable to particulate air pollution in English local authorities and regions, as an indicator within the Public Health Outcomes Framework for England, published by the Office for Health Improvement and Disparities. This framework is available at the following link:
The UKHSA provides the scientific secretariat to the Committee on the Medical Effects of Air Pollutants, an expert committee of the Department, which advises the Government on matters concerning the health effects of air pollutants. Further information on this committee is available at the following link:
https://www.gov.uk/government/groups/committee-on-the-medical-effects-of-air-pollutants-comeap
Asked by: Andrew Rosindell (Conservative - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much funding was provided for (a) dementia and (b) cancer research in the 2022-23 financial year.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Government responsibility for delivering dementia research and dementia research funding is shared between the Department of Health and Social Care, with research delivered by the National Institute for Health and Care Research (NIHR), and the Department for Science Innovation and Technology, with research delivered via UK Research and Innovation.
In 2022/23, we estimate that total Government spend on dementia research was £99.9 million, with £35.1 million of this being via the NIHR. The Department of Health and Social Care spends £1.3 billion per year on health research through the NIHR. NIHR research expenditure for all cancers was £121.8 million in 2022/23, and the NIHR spends more on cancer than any other disease group.
The NIHR funds research in response to proposals received from scientists rather than allocating funding to specific disease areas. The NIHR welcomes funding applications for research into any aspect of human health, including all cancers and dementia types. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.
Asked by: Douglas Ross (Conservative - Moray)
Question to the Department for Environment, Food and Rural Affairs:
To ask the Secretary of State for Environment, Food and Rural Affairs, what steps he is taking to help protect farmers against new strains of potato blight.
Answered by Mark Spencer - Minister of State (Department for Environment, Food and Rural Affairs)
Integrated Pest Management (IPM) is a holistic approach that carefully considers all available plant protection methods and keeps the use of pesticides to levels that are ecologically and economically justified. IPM lies at the heart of our approach to minimise the environmental impact of pesticides and is a key tool for businesses facing the challenges of pesticide resistance, removal of pesticides from the market, and changing pest pressures due to climate change. Within the National Action Plan for the Sustainable Use of Pesticides (NAP) we will set out our policies to increase the uptake of IPM by farmers, growers, amenity managers and amateur gardeners.
Having an IPM approach can reduce the risks associated with pesticides, combat pesticide resistance, and support sustainable agricultural productivity. IPM aims to diversify crop protection and reduce reliance on the use of chemical pesticides by making use of lower risk alternatives and promoting natural processes. For example, creating habitats for natural predators of plant pests, or using crop rotations to break pest, weed and disease cycles. When alternative methods are ineffective or unavailable, IPM also aims to optimise and minimise the use of chemical pesticides through targeted and precise application.
We have recently commissioned a package of research projects that will bring together scientific evidence underpinning IPM and to look at ways of further encouraging its uptake. This work will support farmers’ access to the most effective IPM tools available and ensure that we understand changing trends in pest threats across the UK.
Defra is also a partner in the European Research Area Network (ERA-Net) Co-Fund on Sustainable Crop Production (SusCrop). This research network aims to enhance cooperation and coordination of different national and regional research programmes focussing on agriculture and climate change, sustainable farming systems and biodiversity, sustainable water management, resource efficiency and resilience in the food chain. It also seeks to increase productivity through technological innovation.
Projects within SusCrop ERA-Net include: ‘Eco-friendly solutions for the integrated management of late and early blight of potatoes (ECOSOL)’ which aims to Identify Effective Biological Control Agents and Plant Resistance Inducers for the Control of Potato Late Blight in the field.
Asked by: Lord Bishop of St Albans (Bishops - Bishops)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to prioritise research into variation of the prevalence of prostate cancer among different ethnic groups.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department welcomes the recently announced TRANSFORM trial which aims to save thousands of men each year by finding the best way to screen for prostate cancer across all ethnic groups. It will be spread across the United Kingdom, although final decisions on specific locations are yet to be taken. Men will be invited to participate via their general practices. This study, led by Prostate Cancer UK and supported by the Government among others, will also aim to address some of the inequalities that exist in prostate cancer diagnosis today by ensuring that one in ten of the trial participants will be black men, who are three times overrepresented compared to the population of men aged between 45 and 75 years old as based on 2021 census data.
More broadly, the National Institute for Health and Care Research (NIHR) funds research in response to proposals received from scientists and commissioned calls rather than allocating funding to specific disease areas. It welcomes funding applications for research into any aspect of human health, including prostate cancer. Applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money and scientific quality.
In addition, to raise awareness of prostate cancer in this group, Leicester’s Centre for BME Health has developed a toolkit in partnership with the NIHR with guidance on how to start conversations about prostate cancer and overcome barriers to diagnosis.
Asked by: Ellie Reeves (Labour - Lewisham West and Penge)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will commission research into the impact of (a) autism and (b) ADHD on women.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is currently funding research to address measurement bias in the assessment of the presentation of autism in women, and to develop a new psychometric tool assessing the female-dominant phenotype of autism. The NIHR previously funded a study to improve the accuracy and efficiency of autism assessment for adults which, while not specific to women, will be relevant to their experiences of receiving a diagnosis. The NIHR has also funded research into topics that impact autistic individuals differently, for example how to adapt suicide safety plans to address self-harm, suicidal ideation, and suicide behaviours in autistic adults.
The NIHR welcomes funding applications for research into any aspect of human health, including the impact of autism and attention deficit hyperactivity disorder on women. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity.
Asked by: Ellie Reeves (Labour - Lewisham West and Penge)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will commission research into the reasons for which autistic women are more likely to suffer from premenstrual dysphoric disorder throughout their lives.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is not currently funding any specific research to understand the reasons why autistic women are more likely to suffer from premenstrual dysphoric disorder, but welcomes funding applications for research into any aspect of human health. Applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money, and scientific quality.
Asked by: Ellie Reeves (Labour - Lewisham West and Penge)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will commission research into the impact of hormonal changes on neurodiverse women throughout their lives.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is not currently funding any specific research into the impact of hormonal changes on neurodiverse women, but welcomes funding applications for research into any aspect of human health. Applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money, and scientific quality.
Asked by: Richard Burgon (Labour - Leeds East)
Question to the Foreign, Commonwealth & Development Office:
To ask the Minister of State, Foreign, Commonwealth and Development Office, how many foreign officials have been granted special mission status to visit the UK in each year since 2011; and if he will list the (a) names and (b) country of origin of those officials.
Answered by David Rutley - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)
As set out in 2013 by the former Foreign Secretary William Hague, a special mission is a 'temporary mission, representing a state, which is sent by one state to another with the consent of the latter, in order to carry out official engagements on behalf of the sending state'. Since starting to issue special mission status (SMS) certificates in 2013, the FCDO has given consent for 57 special mission status visits to the UK for the following officials and their delegations:
2013 | Israel | · Maj. Gen. (res) Amos Yadlin, Former Chief of Military Intelligence DMI; Deputy Commander of Air Force · Maj. Gen. (res) Doron Almog Senior Adviser on Beduoin Issues (cancelled) · Lt. Gen. Benjamin Gantz, Chief of Defence Staff, Israeli Defence Forces (IDF) · Dr. Yuval Steinitz, Minister of International Affairs, Strategy and Intelligence |
2014 | Egypt | · Dr. Mohamed Mahmoud Abdul Nasr, Minister of Education (cancelled) · Mr Mounir Faqhry Abdel Noor, Minister for Foreign Trade and Investment · Ambassador Yasser Atef, Deputy Assistant Minister for European Affairs · Dr Sherif Mohamed Ali Hammad, Minister of Scientific Research · Lt. Gen. Mahmoud Hegazy, Chief of Staff of Egyptian Armed Forces · Mr Sameh Shoukry, Minister for Foreign Affairs · Dr Mahamoud Aboel Nasr, Minister of Education |
Israel | · Ms Tzipi Livni, Minister for Justice · Ms Tzipi Livni, Minister for Justice | |
Iran | · Mr Ebrahim Rahimpour, Deputy Foreign Minister for Asia and Oceania | |
2015 | Egypt | · Dr Mahmoud Abdoul Nasr, Minister of Education · Mr Ashraf Salman, Minister of Investment · Mr Ashraf Salman, Minister of Investment · Dr Hany Kadry Demain, Minister of Finance · Prof. Dr SHerif Hammad, Minister of Scientific Research · Sheikh Dr Ahmed Al-Tayyeb, Grand Imam · Mr Sameh Hassan Shoukry, Foreign Minister · Lt. Gen. Mahmoud Hegazy, Chief of Defence Staff · Mr Tarek Kabil, Minister of Trade and Industry · Mj. Gen. Mohamed Elkeshky, Assistant to the Minister of Defence for International Relations · Mr Khaled Fawzy, Chief of General Intelligence · Dr Ahmed Emad Eldin Rady, Minister for Health · President Sisi's Advance Delegation · President Sisi's Delegation · Major General Mohammad Farag Elshahat, Head of Military Intelligence |
Israel | · Ms Tzipi Livni, Member of the Israeli Knessett · Delegation of Former Security Officials · Mr Benjamin Netanyahu, Prime Minister · Maj. Gen. Herzi Halevi, Chief of Military Intelligence | |
Qatar | · H.E, Dr. Ali bin Fetais Almarri, Attorney General | |
2016 | Egypt | · Mr Ashraf El Sheihy, Minister of Higher Education and Scientific Research · Mr Saad Elgyoushi, Minister of Higher Education and Scientific Research · Mr Sameh Hassan Shoukry, Foreign Minister |
Qatar | · H.E, Dr. Ali bin Fetais Almarri, Attorney General. | |
Israel | · Ms Tzipi Livni, Member of the Israeli Knessett · Maj. Gen. (ret) Amos Yadlin, Director, Institute for National Security Studies (INSS) · Mr Shaul Mofaz, Former CDS and Minister of Defence · Mr Avi Dichter, Member of the Israeli Knessett | |
Rwanda | · Mr James Kararebe, Minister of Defence | |
2017 | Egypt | · Lt. Gen. Mahmoud Ibrahum Mahmoud Hegazy, Chief of Staff of the Egyptian Armed Forces. · Eng. Sherif Ismail, Prime Minister · Mr Sameh Shoukry, Minister of Foreign Affairs |
2018 | Saudi Arabia | · Crown Prince Mohammed bin Salman Al Saud, Crown Prince of Saudi Arabia |
2019 | Egypt | · Mr Mahmoud Sharawy, Minister of Local Development · Mr Kamel El-Wazer, Minister of Transport |
2020 | Egypt | · Mr Abdel Fattah Alsisi, President of the Arab Republic of Egypt · Mr Kamel El-Wazer, Minister of Transport |
Saudi Arabia | · Colonal Turki Al Maliki, Coalition Spokesman and Joint Head of Delegation | |
2021 | Egypt | · Mr Kamel El-Wazer, Minister of Transport |
2022 | Egypt | · Mr Kamel El-Wazer, Minister of Transport · Mr Sameh Shoukry, Minister of Foreign Affairs |
Saudi Arabia | · Crown Prince Mohammed bin Salman Al Saud, Crown Prince of Saudi Arabia. (cancelled) | |
2024 | Israel | · Mr Benny Gantz, Minister of the State of Israel |
Asked by: Stephanie Peacock (Labour - Barnsley East)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, what discussions his Department has had with the Industrial Injuries Advisory Council on classification as an industrial injury of neurodegenerative conditions linked to repeated head impacts.
Answered by Mims Davies - Minister of State (Department for Work and Pensions)
The Department is advised by the Industrial Injuries Advisory Council (IIAC), an independent scientific body, on changes to the list of occupational diseases for which Industrial Injuries Disablement Benefit (IIDB) can be paid. IIAC is currently considering whether there is a link between certain neurodegenerative diseases and professional sportspeople.
IIAC has reviewed over 100 studies relating to ALS (amyotrophic lateral sclerosis) and will need to give more consideration to the evidence before it can make a decision. IIAC will also likely consult experts (neurologists) in this field and will then publish its findings when the investigation is complete.
It would be premature to speculate on how the Council’s investigation will progress or whether there is enough evidence of a link between certain neurodegenerative diseases and professional sportspeople to meet the threshold for a new ‘prescribed disease’ to be recommended by IIAC for the purpose of IIDB entitlement.
If recommendations are made by IIAC on this matter, they will be carefully considered by the Department.